For the first time, a global consensus positionstatementon use of testosterone therapy for women with low sexual desire has been published in various medical journals. The statementwhich is completed and should be read in its entiretywas prompted because of the uncertain benefits and risks of treating women with testosterone. In many countries, the therapy is prescribed off-label, using either testosterone formulations approved for men with dose modification, or as compounded therapies.
There is a need to delineate, based on available evidence, when a trial of testosterone therapy is appropriate, to enable women who might benefit to be treated, and equally when it is inappropriate to protect women against inappropriate treatment, said lead author Susan Davis MBBS, FRACP, PhD, FAHMS, president of the International Menopause Society and chair of Women's Health at Monash University in Melbourne, Australia.
Dr. Davis toldContemporary OB/GYNthat testosterone therapy is effective in women with low sexual desire that causes them distress, as long as their blood levels are within the normal premenopausal range.
There is currently no other clinical indication for testosterone therapy for women, according to Dr. Davis.
In such women, there is no evidence of serious adverse events, she said. Few women will experience an increase in hair growth or acne, and when either occurs the effects are mild.
Therapy does not cause alopecia, clitoromegaly or voice change. However, the safety of long-term testosterone therapy has not been determined.
The recommendations are based on findings from blinded placebo/comparator randomized clinical trials (RCTs) of at least 12 weeks duration of reported outcomes. The authors noted that the diagnosis of hypoactive sexual desire disorder/dysfunction (HSDD) should include a full clinical assessment. Other factors contributing to female sexual dysfunction (FSD) must also be identified and addressed before beginning testosterone therapy. But a blood total testosterone level should not be used to diagnose HSDD.
Treatment of HSDD should be limited to testosterone formulations that achieve blood concentrations of testosterone that approximate premenopausal physiological concentrations. Given the absence of any approved female product by a national regulatory body, male formulations can be judiciously used in female doses, but blood testosterone concentrations must be routinely monitored.
The statement recommends against using compounded testosterone. Inaddition, data are insufficient on which to base a recommendation for use of testosterone in premenopausal women to treat sexual function or any other outcome.
Conversely, testosterone therapy does not increase mammographic breast density nor does short-term transdermal testosterone therapy impact breast cancer risk. However, data from the RCTs are insufficient to gauge long-term breast cancer risk.
But there is strong evidence in the literature that appropriate testosterone treatment benefits sexual function, with an average of one satisfying sexual event per month and increases in the subdomains of sexual desire, arousal, orgasmic function, pleasure and sexual responsiveness, along with a reduction in sexual distress.
It is our hope that our global consensus statement will encourage regulators to approve a testosterone formulation for women, Dr. Davis said.
The statement also advocates more research on testosterone therapy for women, plus developing and licensing testosterone products indicated specifically for women.The position statement has been endorsed by more than a dozen leading societies, including the International Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, and The International Society for Sexual Medicine.
Disclosures:
Susan Davis receives honoraria from Besins Healthcare and Pfizer Australia. She is also a consultant to Que Oncology.
See the original post here:
Global consensus statement on using testosterone therapy for women - Contemporary Obgyn
- Testosterone Therapy - Royal Men's Medical Center - December 10th, 2019
- BioTE Medical Founder and Chairman Warns of Potential Serious Impact on Women's Health from Recent Position Statement on Women's Testosterone Therapy... - December 10th, 2019
- Testosterone Replacement Therapy Market Expected to Deliver Dynamic Progression until 2028| AbbVie, Endo International, Eli lilly - Breaking News... - December 10th, 2019
- Testosterone Replacement Therapy Market Top Players (Endo International, AbbVie, Eli lilly, Pfizer, Actavis, Bayer, Novartis, Teva, Mylan,... - December 10th, 2019
- People Are Poisoning Themselves With Essential Oils. Please Don't - IFLScience - December 10th, 2019
- What are the signs of low testosterone levels in men? - Times of India - December 8th, 2019
- Relugolix Induces Sustained Testosterone Reduction in Advanced PC, Phase 3 Trial Results Show - Prostate Cancer News Today - December 8th, 2019
- Surgeons Transplant a Testicle From One Brother to His Twin - The New York Times - December 8th, 2019
- Two teams 'full of testosterone': Ducks ready for grudge rematch with Capitals - The Athletic - December 8th, 2019
- What are the rules for trans athletes in football? - Goal.com - December 8th, 2019
- Testosterone: What It Can And Can't Do, Signs You're Low, And How To Increase It - Men's Health - December 8th, 2019
- Global Testosterone Replacement Therapy Market Insights, Growth Analysis, Forecasts to 2025: Endo International, AbbVie, Eli lilly, Pfizer, Actavis ,... - December 8th, 2019
- Prostate Cancer Development May Be Linked to High Blood Levels of 2 Hormones, Study Says - Prostate Cancer News Today - December 8th, 2019
- Transitioning: a threat to our children - Spiked - December 8th, 2019
- Testosterone Replacement Therapy Market to See Admirable Grrowth by 2024 According to a New Research Report - Kentucky Reports - December 3rd, 2019
- Expanded U.S. NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational - Financial Post - December 3rd, 2019
- The Wolf of Wall Street Immersive Experience, review: an overlong scenario with the barely contained testosterone of a stag party - inews - December 3rd, 2019
- Daughters of women with PCOS face five times greater risk - The Guardian - December 3rd, 2019
- Where Have All the Alphas Gone? | Columns - PJ Media - December 3rd, 2019
- The Pill Can Make You Less Attracted to Jerks, and Other Surprising Facts About Birth Control - Yahoo Lifestyle - December 3rd, 2019
- Testosterone Replacement Therapy Market To Witness Robust Expansion Throughout The Forecast Period 2019 2025 - Statsflash - December 3rd, 2019
- What supplements in the Exchange are worth your money? Part 3 - We Are The Mighty - December 3rd, 2019
- Should You Worry About Swollen Testicles? - University of Utah Health Care - November 22nd, 2019
- Symptoms of Low Testosterone in Men - FortuneHerald - November 22nd, 2019
- Testosterone Replacement Therapy Market To Witness Huge Growth in 2024 - Downey Magazine - November 22nd, 2019
- At-home testing kits could help Maryland residents engage in their health - WBAL TV Baltimore - November 22nd, 2019
- 8 Awful Things That Happen to You After You Turn 30 (And What You Can Do to Stop Them) - Mandatory - November 22nd, 2019
- Lipocine Announces Closing Of Public Offering Of Common Stock And Warrants - The Herald Journal - November 22nd, 2019
- Why men who compete as female will always have an unfair advantage over real women - Lifesite - November 22nd, 2019
- Lipocine Announces Pricing Of Public Offering Of Common Stock And Warrants - The Herald Journal - November 22nd, 2019
- Crush Your Fitness Goals with This Fat Burner and Testosterone Booster - Men's Journal - November 15th, 2019
- Acerus Reports Third Quarter and Year-to-Date Fiscal 2019 Financial Results - Business Wire - November 15th, 2019
- Hormone therapy offered by Student Health Service - UWEC Spectator - November 15th, 2019
- Same-sex relationship to unnatural testosterone, why Dutee Chand is the only Indian to feature on 'TIME 100 Next' - Free Press Journal - November 15th, 2019
- Testosterone therapy prescription linked to increased VTE risk in JAMA study - Specialty Medical Dialogues - November 15th, 2019
- New book refutes 'boys will be boys' - Futurity: Research News - November 15th, 2019
- A Myth Of Masculinity: The Truth About Testosterone - KGOU - November 12th, 2019
- What is Testosterone and Why is it Important? - News Anyway - November 12th, 2019
- Value and Size Of Testosterone Replacement Therapy Market From 2019 To 2024: Detailed Research Report - The Denton Chronicle - November 12th, 2019
- Testosterone Replacement Therapy Industry: Time to Invest in emerging Markets | Endo International, Pfizer, Novartis - News Description - November 12th, 2019
- Global Testosterone Replacement Therapy Market Size And Share 2019: With Top Manufacturers, Applications, Key Regions, Growth Opportunities Forecast... - November 12th, 2019
- Testosterone Replacement Therapy: Controversy and Trends - Medscape - November 11th, 2019
- Lawsuit claims contract breached over transgender testosterone therapy - The San Diego Union-Tribune - November 11th, 2019
- Traces of testosterone: US womens tennis star provisionally suspended for doping violation - RT - November 11th, 2019
- LANE ONE: IAAF taking the lead in transgender regulation, working with other IFs on testosterone levels - The Sports Examiner - November 11th, 2019
- Nike will look into runner Mary Cain's allegations of abuse - Minneapolis Star Tribune - November 11th, 2019
- Everything you need to know about steroids - RTE.ie - November 11th, 2019
- The double standard of feminism - University Star - November 11th, 2019
- Hearing into Team Sky doctor's lies in danger of being sent down blind alleys while the dirty secrets of Dave Brailsford's project stay uncovered -... - November 11th, 2019
- Brazil Nuts and Testosterone: Is There a Link? - Healthline - October 30th, 2019
- Side Effects of Hormone Therapy - Prostate Cancer Foundation - October 30th, 2019
- Is testosterone really the answer to my post-menopausal sexual problems? - The Guardian - October 30th, 2019
- Women are more likely to be diagnosed with depression. MSU study may help explain why. - Michigan Radio - October 30th, 2019
- Former Team Sky doctor Richard Freeman to admit to a lot of lies - Irish Times - October 30th, 2019
- Cory Booker Condemns 'Lock Him Up' Chant Against The President - The Daily Wire - October 30th, 2019
- Why has the field of male contraception not seen any progress? - Business Insider India - October 30th, 2019
- The link between anabolic steroids and gynecomastia in men - MENAFN.COM - October 30th, 2019
- Optimizing Diagnosis and Management of PCOS in Pediatric Patients - Endocrinology Advisor - October 22nd, 2019
- How To Deal When You Don't Want To *Do It* As Much As Your SO - Women's Health - October 22nd, 2019
- Testosterone Replacement Therapy Market Growing Demand, Analysis by Key Players-Bayer, Novartis - The Market Journal - October 22nd, 2019
- Krygen XL has now become the best priced and best reviewed male enhancement supplement in the UK - I'm Herald - October 22nd, 2019
- Testosterone Booster Market Distinguished Technology Development with Major Production Goals Analysis by 2026 - Connecting Investor - October 22nd, 2019
- Katrina Karkazis on the Science of Masculinity - GQ - October 20th, 2019
- Sarah Connor Tested Testosterone To Make Her Role In TERMINATOR - Somag News - October 20th, 2019
- Can't Grow a Full Beard? There's an Explanation for That - Health Essentials from Cleveland Clinic - October 20th, 2019
- Positive Association between Preoperative Total Testosterone and Lymph Node Invasion in Intermediate Risk Prostate Cancer. - UroToday - October 20th, 2019
- SIU 2019: Timing of ADT in the Era of STAMPEDE and LATITUDE - UroToday - October 20th, 2019
- A clinic treated a fatigued 41-year-old with testosterone. A month later he had a stroke. - CBS News - October 17th, 2019
- Harvard says masculinity and testosterone are not 'connected' - The College Fix - October 17th, 2019
- Associations Between Sex Hormones and Asthma in Adults - Pulmonology Advisor - October 17th, 2019
- Science! Harvard Disputes the Idea That Testosterone and Masculinity are Connected - legal Insurrection - October 17th, 2019
- Global Testosterone Replacement Therapy Market Industry: A Latest Research Report to Share Market Insights and Dynamics - Healthcare News - October 17th, 2019
- Testosterone Replacement Therapy Market: An Insight on the Important Factors and Trends Influencing the Market - Online News Guru - October 17th, 2019
- Nike closing Oregon Project in wake of Salazar doping ban - CTV News - October 17th, 2019
- Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth - The Cardiology Advisor - October 14th, 2019
- Nike to Shut Down Salazars Oregon Project - The New York Times - October 12th, 2019
- Nike Oregon Project will 'wind down' after Alberto Salazar's doping violation ban - KGW.com - October 12th, 2019
- How to know if you have low testosterone. - KNWA - September 27th, 2019
- Britain's Sharp eliminated in opening 800 metres heat - Euronews - September 27th, 2019
- Transgender Puberty Blocking Drug Linked To Thousands Of Deaths, FDA Data Reveals - The Daily Wire - September 27th, 2019